You are here » Home » Companies » Company Overview » Everest Organics Ltd

Everest Organics Ltd.

BSE: 524790 Sector: Health care
NSE: N.A. ISIN Code: INE334C01029
BSE LIVE 12:42 | 14 Dec 133.00 -4.00
(-2.92%)
OPEN

139.00

HIGH

139.00

LOW

132.00

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 139.00
PREVIOUS CLOSE 137.00
VOLUME 4247
52-Week high 168.75
52-Week low 47.60
P/E 54.73
Mkt Cap.(Rs cr) 106
Buy Price 133.00
Buy Qty 360.00
Sell Price 136.90
Sell Qty 10.00
OPEN 139.00
CLOSE 137.00
VOLUME 4247
52-Week high 168.75
52-Week low 47.60
P/E 54.73
Mkt Cap.(Rs cr) 106
Buy Price 133.00
Buy Qty 360.00
Sell Price 136.90
Sell Qty 10.00

Everest Organics Ltd. (EVERESTORGANICS) - Company History

Everest Organics was incorporated at Hyderabad in Feb.'93. It was promoted by S K Srihari Raju and S K Chittiramabhadra Raju. The company set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations. It came out with a public issue in Jan.'95 to part-finance the project. Commercial production of ciprofloxacin and omerprazole commenced in Feb.'96. The company preferred to manufacture para hydroxy phynyl glycin (PHPG), but due to market conditions, it decided to drop manufacturing of PHPG and has decided to enhance the capacity of ciprofloxacin from 30 tpa to 120 tpa and also to manufacture enrofloxacin/naproxen. The company has increased its installed capacity of Benzimidazole by 60 tpa there by taking its capacity to 120 tpa.The installed capacity of Omeprazole Op Sulphide was increased from 15 TPA to 30 TPA.